Marca Nominativa depositada no INPI em 06/08/2021 por COMBINEXT LLC, processo nº 501651471, nas classes 01, 05, 42. Registro em vigor até 06/08/2031.
| Número do processo | 501651471 |
|---|---|
| Situação | Registro de marca em vigor (Madri) |
| Apresentação | Nominativa |
| Natureza | Madri Produto/Serviço |
| Data do depósito | 06/08/2021 |
| Data da concessão | 18/04/2023 |
| Vigência até | 06/08/2031 |
| Titular | COMBINEXT LLC |
| UF · País | — · US |
Chemical compositions and preparations for environmental testing and research.;
Pharmaceutical composition for medical purposes for use in targeted pharmaceutical therapies for the treatment of infectious diseases and disorders; pharmaceutical composition for medical purposes for use in targeted pharmaceutical therapies for the treatment of pulmonary viral infection; delivery agents for medical purposes for use in targeted pharmaceutical therapies for the treatment of infectious diseases; delivery agents for medical purposes for use in targeted pharmaceutical therapies for the treatment of pulmonary viral infection; drug delivery agents for medical purposes consisting of compositions that facilitate the delivery of a wide range of pharmaceutical based therapies; vaccines; vaccine preparations; medical preparations for the treatment of infectious diseases; pharmaceutical preparations and substances for the treatment of infectious diseases and disorders; pharmaceutical preparations and substances; chemical preparations for the treatment of diseases; chemical preparations for pharmaceutical purposes; chemical preparations for medical purposes; pharmaceutical compositions and preparations containing lipophilic stains for scientific testing and research, biological testing and research, diagnostic testing and research, and environmental testing and research; pharmaceutical compositions and preparations for the detection of pathogens; pharmaceutical compositions and preparations containing lipophilic stains for the detection of pathogens; pharmaceutical compositions and preparations for environmental testing provided as part of a kit; kits for environmental use comprised of pharmaceutical compositions and preparations containing lipophilic stains; pharmaceutical compositions and preparations for the detection of pathogens through use of lateral flow assays, immunochemistry, affinity chromatography, microfluidics, or nanotechnology.;
Research services relating to treatments for infectious diseases; research services related to the development of vaccines; research and development of drug delivery platforms for use in the treatment of infectious diseases and disorders; research and development of compositions for use in targeted pharmaceutical therapies for the treatment of infectious diseases and disorders; scientific and technological services, namely, scientific analysis in the field of research and development relating to compositions for use in the treatment of infectious diseases; scientific and technological services, namely, research and development relating to compositions for use in the treatment of infectious diseases; scientific and technological services, namely, research and development relating to compositions for use in the treatment of pulmonary viral infections; design and development of compositions for use in the treatment of infectious diseases; consulting services relating to the design and development of compositions for use in the treatment of infectious diseases; consulting services relating to the design and development of targeted pharmaceutical therapies; research services relating to the detection of pathogens; research and development of compositions and preparations for use in the detection of pathogens; scientific and technological services, namely, scientific analysis in the field of research and development relating to compositions and preparations for use in the detection of pathogens; scientific and technological services, namely, research and development relating to compositions and preparations for use in the detection of pathogens; design and development of compositions for use in the detection of pathogens; consulting services relating to the design and development of compositions and preparations for use in the detection of pathogens.;
Receba um e-mail a cada novo despacho publicado na RPI para o processo 501651471 — exigência, oposição, deferimento, prazo de pagamento — e quando alguém depositar uma marca parecida.
Monitorar esta marca Ver marcas parecidas3 despacho(s) publicado(s) na Revista da Propriedade Industrial.